Issuer · CIK 0001662774
QNCX — Quince Therapeutics, Inc.
Recent filings
- Jun 15, 2026·Form 4·Other—
QNCX/Quince Therapeutics, Inc.
Lamond David · director
Mechanical filing
AI thesis skipped - Jun 15, 2026·Form 4·Other—
QNCX/Quince Therapeutics, Inc.
Senner Christopher J. · director
Mechanical filing
AI thesis skipped - Jun 11, 2026·Form 4·Other—
QNCX/Quince Therapeutics, Inc.
Roberts Brigette · Chief Corp. Affairs Officer
Mechanical filing
AI thesis skipped